1. Home
  2. UBXG vs GTBP Comparison

UBXG vs GTBP Comparison

Compare UBXG & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • GTBP
  • Stock Information
  • Founded
  • UBXG 2018
  • GTBP 1965
  • Country
  • UBXG China
  • GTBP United States
  • Employees
  • UBXG N/A
  • GTBP N/A
  • Industry
  • UBXG
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • GTBP Health Care
  • Exchange
  • UBXG Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • UBXG 6.1M
  • GTBP 6.6M
  • IPO Year
  • UBXG 2024
  • GTBP N/A
  • Fundamental
  • Price
  • UBXG $3.08
  • GTBP $2.13
  • Analyst Decision
  • UBXG
  • GTBP Strong Buy
  • Analyst Count
  • UBXG 0
  • GTBP 1
  • Target Price
  • UBXG N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • UBXG 325.4K
  • GTBP 23.9K
  • Earning Date
  • UBXG 12-24-2024
  • GTBP 11-14-2024
  • Dividend Yield
  • UBXG N/A
  • GTBP N/A
  • EPS Growth
  • UBXG N/A
  • GTBP N/A
  • EPS
  • UBXG N/A
  • GTBP N/A
  • Revenue
  • UBXG $51,600,106.00
  • GTBP N/A
  • Revenue This Year
  • UBXG N/A
  • GTBP N/A
  • Revenue Next Year
  • UBXG N/A
  • GTBP N/A
  • P/E Ratio
  • UBXG N/A
  • GTBP N/A
  • Revenue Growth
  • UBXG N/A
  • GTBP N/A
  • 52 Week Low
  • UBXG $0.26
  • GTBP $1.92
  • 52 Week High
  • UBXG $35.44
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • UBXG N/A
  • GTBP 40.32
  • Support Level
  • UBXG N/A
  • GTBP $2.41
  • Resistance Level
  • UBXG N/A
  • GTBP $3.40
  • Average True Range (ATR)
  • UBXG 0.00
  • GTBP 0.30
  • MACD
  • UBXG 0.00
  • GTBP -0.04
  • Stochastic Oscillator
  • UBXG 0.00
  • GTBP 6.09

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: